tradmap

HBIO Earnings HARVARD BIOSCIENCE INC

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$1 -$1 $0 $0 2014 2015 2016 2017 2018 2019 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $60M $121M 2017 2018 2019 2020 2021 2022 2023 2024 2025 2025
Revenue
Net income (annual)
-$57M -$28M $0 2017 2018 2019 2020 2021 2022 2023 2024 2025 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$11 -$0 $11 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $14M $28M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$50M -$25M $18000 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–60 of 60
Q2 20262026-06-30-0.642026-08-1110-Q
Q1 20262026-03-31-0.772026-05-1210-Q
Q4 2025 (derived)2025-12-3110.692026-03-1310-K
FY 20252025-12-31-1.282026-03-1310-K
Q3 20252025-09-30-0.032025-11-0610-Q
Q2 20252025-06-30-0.522025-08-1110-Q
Q1 20252025-03-31-11.422025-05-1210-Q
Q4 2024 (derived)2024-12-311.002025-03-1410-K
FY 20242024-12-31-0.282025-03-1410-K
Q3 20242024-09-30-0.112024-11-0810-Q
Q2 20242024-06-30-0.072024-08-0810-Q
Q1 20242024-03-31-1.102024-05-0710-Q
Q4 2023 (derived)2023-12-31-0.042024-03-0710-K
FY 20232023-12-31-0.082024-03-0710-K
Q3 20232023-09-30-0.032023-11-0710-Q
Q2 20232023-06-30-0.022023-08-0810-Q
Q1 20232023-03-310.012023-04-2610-Q
Q4 2022 (derived)2022-12-31-0.04——
FY 20222022-12-31-0.23——
Q3 20222022-09-30-0.08——
Q2 20222022-06-300.062022-08-0410-Q
Q1 20222022-03-31-0.17——
Q2 20212021-06-30-0.01——
Q2 20202020-06-30-0.042020-08-1010-Q
Q1 20202020-03-31-0.122020-05-0810-Q
Q4 20192019-12-310.022020-03-1610-K
FY 20192019-12-31-0.122020-03-1610-K
Q3 20192019-09-30-0.072019-11-0810-Q
Q2 20192019-06-30-0.012019-08-0810-Q
Q1 20192019-03-31-0.062019-05-0810-Q
Q4 20182018-12-310.082019-03-1810-K
FY 20182018-12-31-0.082019-03-1810-K
Q3 20182018-09-30-0.012018-11-0110-Q
Q2 20182018-06-30-0.042018-08-0210-Q
Q1 20182018-03-31-0.112018-05-1010-Q
Q4 20172017-12-310.032018-03-1610-K
FY 20172017-12-31-0.022018-03-1610-K
Q3 20172017-09-30-0.012017-11-0210-Q
Q2 20172017-06-30-0.012017-08-0310-Q
Q1 20172017-03-31-0.032017-05-0810-Q
Q4 20162016-12-31-0.042017-03-1710-K
FY 20162016-12-31-0.132017-03-1710-K
Q3 20162016-09-30-0.052016-11-0310-Q
Q2 20162016-06-30-0.022016-08-0410-Q
Q1 20162016-03-31-0.022016-05-1610-Q
Q4 20152015-12-31-0.512016-04-2910-K
FY 20152015-12-31-0.572016-04-2910-K
Q3 20152015-09-30-0.022015-11-0510-Q
Q2 20152015-06-300.012015-08-0610-Q
Q1 20152015-03-31-0.042015-05-0710-Q
Q4 20142014-12-310.002015-03-1210-K
FY 20142014-12-310.072015-03-1210-K
Q3 20142014-09-300.022014-11-0610-Q
Q2 20142014-06-300.032014-08-0710-Q
Q1 20142014-03-310.022014-05-0810-Q
Q4 20132013-12-31-0.022014-03-1410-K
FY 20132013-12-31-0.062014-03-1410-K
Q3 20132013-09-30-0.032013-11-0810-Q
Q2 20132013-06-30-0.012013-08-0910-Q
Q1 20132013-03-310.002013-05-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.